I must have been unclear ,, absolutely no Blame to be placed on...

I must have been unclear ,, absolutely no Blame to be placed on RAC Management more so a comparrison that SNT would benefit from the same PR and market Messaging that RAC carried off perfectly ,,, if there was ever a case of Capitalising on Progress , then the Gold medal would go to RAC Management.. so my quote of "Could only imagine if RAC Management were behind this one" was an analogy of "IF" Race were behind SNT Marketing and PR,, heck SNT was at 9.5c looking to climb into double digits and then SNT Management went ...............................well went .................. zzzz

4C today? maybe that's what management believe market interaction is, 4C is a mandatory regulated report,,,not a market update or Investor Presentation,,, during this Tariff Tantrum and complete market turmoil SNT has chosen to not release a SH update?

Other Biotechs are recovering well ,,, but as a response to Market Intelligence and pushing the Positives of the Company and Technology to Investors.

Every Company has its own style but as you would have seen Money is migrating to those who are putting in the effort to promote their Companies and keep then current...

My Grandad had a saying "Reward comes after Effort , just like in the Dictionary"

When operating in a sector that has very few revenuing companies there is strong competition for funds,,, if your competition is pushing their Company as a Significant Investment Opportunity and you decide your strategy is not to, then you cant expect the same results that others enjoy..


Beauty of SNT is IMHO has incredibly advanced Treatments completing their Phase II Trialing of 4 Candidates that are finishing a decade long development programme..

Confident the Company will push the results in their own way BUT always nice to promote results from a strongly based SP 8/9/10c to really amplify SH returns,,,, and not just make up lost ground...

Discussing SNT with a couple of other SH , one pointed out that during the previous presentation that Gary stated there are several interested parties in SNT 5505.... and from experience I can see the Phase II results may well be the catalyst for Big Pharma to step in early here for an early partnership or T/O agreement..

SNT is in my Top 5 and has near term catalysts NZT